Last reviewed · How we verify
glucose
glucose is a drug. It is currently in unknown development for Hypoglycemia.
At a glance
| Generic name | glucose |
|---|---|
| Therapeutic area | Metabolic |
| Phase | unknown |
Approved indications
- Hypoglycemia
Common side effects
Key clinical trials
- Effect of 12-week Bioactive Whey Protein Concentrate Supplementation on the Neuromuscular System of Healthy, Recreationally Active Adults (NA)
- Gerber Pump Trial: Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Real-Time Sensor Augmentation (RTSA) in 0-3 Years Old Diabetes Patients; A One Year Randomized Controlled Clinic (Phase 3)
- Fast-Track Perioperative Care After Elective Colorectal Surgery in Senior Patients. Randomized Controlled Trial (NA)
- Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly: Results of a 5 Years Observational, Open, Prospective Study (N/A)
- Continuous Glucose Monitoring in Kidney Transplant Recipients with Diabetes, Pre-diabetes and Without Diabetes (N/A)
- Effects of Muscle Strength Training on Glycemic Control, Muscle Mass, Muscle Strength and Functional Capacity in Older Adults With Type II Diabetes: A Randomised Controlled Trial (NA)
- An Interventional, Single Arm, Multicenter, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-ACLF for the Treatment of Acute-on-Chronic Liver Failure (ACLF) (Phase 1)
- The EMMED-HF Study: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure (Phase 4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- glucose CI brief — competitive landscape report
- glucose updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about glucose
What is glucose?
glucose is a pharmaceutical drug, indicated for Hypoglycemia.
What is glucose used for?
glucose is indicated for Hypoglycemia.
What development phase is glucose in?
glucose is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Metabolic
- Indication: Drugs for Hypoglycemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing